Axiogenesis

Biotechnology ResearchNorth Rhine-westphalia, Germany2-10 Employees

Axiogenesis is a biotechnology research company based in Cologne, North Rhine-Westphalia, focused on developing in vitro models of healthy and diseased human cell types and tissues. Founded in 2001, it develops and commercializes stem cell–derived cell types and related assays to support drug discovery and life sciences research. Its flagship Cor.4U product provides purified human cardiomyocytes derived from induced pluripotent stem cells for applications ranging from single-cell analysis to high-throughput screening.

The company licenses disease models, such as hypertrophic cardiomyopathy, for compound screening, and offers fee-for-service assays for in vitro toxicology and safety pharmacology. Beyond cardiomyocytes, its pipeline includes neurons and other cell types derived from stem cells to broaden research capabilities.

Sign up for free to view info

Email Format Employee directory